MED19 and prostate carcinoma: Considering that alternative MED19 has high expression in endothelial progenitor cells that decreases upon differentiation and that MED19 protein levels are elevated in prostate tumors and associated with high grade and poor differentiation in other cancers18,19, we hypothesized that alternative MED19 might play a role in prostate cancer progression.